NeuroPace’s Key Presentation at a Major Healthcare Conference
NeuroPace, Inc. (NASDAQ: NPCE) is excited to announce its participation in an upcoming global healthcare conference where the management team will showcase their advancements in epilepsy treatment. The focus will be on the innovative RNS System, which has been pivotal in changing the lives of epilepsy patients.
Conference Details and What to Expect
The presentation is scheduled for a convenient time that aligns with both Eastern and Pacific Time zones, making it accessible to a wider audience. NeuroPace’s management will provide in-depth insights into the company’s mission and how they are setting a new standard in epilepsy care.
Investor Engagement
During the conference, NeuroPace will also host meetings with investors. This is an excellent opportunity for stakeholders to engage directly with the team and learn about ongoing developments and prospects in the field of neuromodulation.
Webcast and Further Information
For those unable to attend the presentation live, there will be a webcast available, ensuring that everyone has access to this important information. Following the event, a replay will be accessible for two weeks, so interested parties can catch up on what they missed. Further details can be found on NeuroPace’s investor website.
About NeuroPace and Its Innovative Solutions
NeuroPace is at the forefront of medical technology dedicated to improving the lives of individuals living with epilepsy. The RNS System is not only a groundbreaking solution but also the first of its kind that responds to brain activity in real-time, delivering personalized treatment as needed. This advancement signifies a major shift towards more effective management of epilepsy, particularly for those whose seizures are typically resistant to medical therapy.
Impact on Patients
Patients who have struggled with traditional therapies may find renewed hope through NeuroPace’s innovative solutions. By focusing on the root cause of seizures, NeuroPace aims to enhance the quality of life for many and reduce the frequency of debilitating episodes, allowing individuals to reclaim their daily activities.
Investor Relations Contact
For further inquiries, investors can reach out to Jeremy Feffer, Managing Director of LifeSci Advisors. The company encourages communications with potential investors to foster better understanding and engagement concerning their transformative work.
Frequently Asked Questions
What will NeuroPace present at the conference?
NeuroPace will present its advancements in treating epilepsy with its RNS System, focusing on how it improves patient outcomes.
How can I access the webcast?
The webcast will be available on NeuroPace's investor website, providing access for those unable to attend live.
Who is the contact for investor relations?
Jeremy Feffer is the contact for investor inquiries and can provide further information on NeuroPace’s initiatives.
What is the RNS System?
The RNS System is a brain-responsive platform that delivers personalized treatment for epilepsy, tailored to the needs of individual patients.
How does NeuroPace impact patients with drug-resistant epilepsy?
NeuroPace provides a novel solution that targets the source of seizures, improving management and potentially reducing the frequency of episodes for patients.
